These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 1663787)

  • 21. Utilizing protein phosphatase inhibitors to define PP2A as a regulator of ataxia-telangiectasia mutated.
    Goodarzi AA; Douglas P; Moorhead GB; Lees-Miller SP
    Methods Mol Biol; 2007; 365():47-59. PubMed ID: 17200553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming collaborations between ras and nuclear oncogenes.
    Ruley HE
    Cancer Cells; 1990; 2(8-9):258-68. PubMed ID: 2223387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signaling and transcriptional changes critical for transformation of human cells by simian virus 40 small tumor antigen or protein phosphatase 2A B56gamma knockdown.
    Moreno CS; Ramachandran S; Ashby DG; Laycock N; Plattner CA; Chen W; Hahn WC; Pallas DC
    Cancer Res; 2004 Oct; 64(19):6978-88. PubMed ID: 15466190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
    Topol LZ; Marx M; Calothy G; Blair DG
    Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic 3,5 adenoise monophosphate and cyclosporin A inhibit cellular proliferation and serine/threonine protein phosphatase activity in pituitary cells.
    Florio T; Perrino BA; Stork PJ
    Endocrinology; 1996 Oct; 137(10):4409-18. PubMed ID: 8828502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein phosphorylation and signal transduction modulation: chemistry perspectives for small-molecule drug discovery.
    Sawyer TK; Shakespeare WC; Wang Y; Sundaramoorthi R; Huang WS; Metcalf CA; Thomas M; Lawrence BM; Rozamus L; Noehre J; Zhu X; Narula S; Bohacek RS; Weigele M; Dalgarno DC
    Med Chem; 2005 May; 1(3):293-319. PubMed ID: 16787325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.
    Yeh E; Cunningham M; Arnold H; Chasse D; Monteith T; Ivaldi G; Hahn WC; Stukenberg PT; Shenolikar S; Uchida T; Counter CM; Nevins JR; Means AR; Sears R
    Nat Cell Biol; 2004 Apr; 6(4):308-18. PubMed ID: 15048125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of protein kinases and phosphatases in signal transduction.
    Hardie DG
    Symp Soc Exp Biol; 1990; 44():241-55. PubMed ID: 1966636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small DNA tumor viruses: large contributors to biomedical sciences.
    Howley PM; Livingston DM
    Virology; 2009 Feb; 384(2):256-9. PubMed ID: 19136134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The serine/threonine phosphatase inhibitor, calyculin A, inhibits and dissociates macrophage responses to lipopolysaccharide.
    Barber SA; Perera PY; McNally R; Vogel SN
    J Immunol; 1995 Aug; 155(3):1404-10. PubMed ID: 7636205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of gene expression by serine/threonine protein phosphatases.
    Schönthal AH
    Semin Cancer Biol; 1995 Aug; 6(4):239-48. PubMed ID: 8541519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of protein phosphorylation in the development of tumors].
    Majercáková P
    Sb Lek; 2000; 101(3):215-28. PubMed ID: 11220149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein serine/threonine phosphatases--new avenues for cell regulation.
    Shenolikar S
    Annu Rev Cell Biol; 1994; 10():55-86. PubMed ID: 7888183
    [No Abstract]   [Full Text] [Related]  

  • 34. How DNA viruses may cause cancer.
    Marx JL
    Science; 1989 Feb; 243(4894 Pt 1):1012-3. PubMed ID: 2538000
    [No Abstract]   [Full Text] [Related]  

  • 35. Involvement of PP2A in viral and cellular transformation.
    Arroyo JD; Hahn WC
    Oncogene; 2005 Nov; 24(52):7746-55. PubMed ID: 16299534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting of PKA, PKC and protein phosphatases to cellular microdomains.
    Sim AT; Scott JD
    Cell Calcium; 1999 Nov; 26(5):209-17. PubMed ID: 10643559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Carcinogenesis: viruses and transposons].
    Zhdanov VM
    Vopr Onkol; 1984; 30(1):98-104. PubMed ID: 6320545
    [No Abstract]   [Full Text] [Related]  

  • 38. Flicking the switches: phosphorylation of serine/threonine protein phosphatases.
    Brautigan DL
    Semin Cancer Biol; 1995 Aug; 6(4):211-7. PubMed ID: 8541516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ser/Thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest.
    Zuo Z; Urban G; Scammell JG; Dean NM; McLean TK; Aragon I; Honkanen RE
    Biochemistry; 1999 Jul; 38(28):8849-57. PubMed ID: 10413457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wip1-dependent signaling pathways in health and diseases.
    Zhu YH; Bulavin DV
    Prog Mol Biol Transl Sci; 2012; 106():307-25. PubMed ID: 22340722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.